Report overview
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccines. This report contains market size and forecasts of DNA Vaccines in global, including the following market information:
Global DNA Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global DNA Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five DNA Vaccines companies in 2022 (%)
The global DNA Vaccines market was valued at US$ 4776.4 million in 2022 and is projected to reach US$ 7856.9 million by 2029, at a CAGR of 7.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
We surveyed the DNA Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, by Type, 2022 (%)
Recombinant Protein Vaccine
Gene-Based Vaccine
Global DNA Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, by Application, 2022 (%)
Human
Animal
Global DNA Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global DNA Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies DNA Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies DNA Vaccines revenues share in global market, 2022 (%)
Key companies DNA Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies DNA Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of DNA Vaccines, market overview.
Chapter 2: Global DNA Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of DNA Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global DNA Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
